Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Timely Delivery

25.07.2012
Ribonucleoside 3'-Phosphates as Pro-Moieties for an Orally Administered Drug

Many drug candidates fail because of low solubility or poor pharmacokinetic behavior. Ron Raines and colleagues at the University of Wisconsin–Madison (USA) have devised a new prodrug strategy to overcome these limitations.



Their approach takes advantage of the capacity of an enzyme prevalent in human serum–pancreatic-type ribonuclease—to catalyze the cleavage of a drug conjugated to a ribonucleoside 3'-phosphate; the results of their work are reported in ChemMedChem.

They demonstrated efficacy by using metronidazole, a sparingly soluble antibiotic that is often administered orally. In the absence of ribonuclease, metronidazole conjugates are stable and inactive. Physiological levels of enzyme render the conjugate toxic to Bacteroides fragilis, a common penicillin-resistant bacillus that is responsible for anaerobic infections.

Alterations to the ribonucleoside enable modulation of key attributes, such as the rate of drug delivery. This study paves the way for further research into the activation and timed release of drugs of varying aqueous solubility.

About the Author
Dr. Ronald T. Raines is the Henry Lardy Professor of Biochemistry and a Professor of Chemistry at the University of Wisconsin–Madison. His research is focused on the chemistry and biology of proteins.
Author: Ronald T. Raines, University of Wisconsin–Madison (USA), http://www.chem.wisc.edu/users/raines
Title: Ribonucleoside 3'-Phosphates as Pro-Moieties for an Orally Administered Drug

ChemMedChem 2012, 7, No. 8, Permalink to the article: http://dx.doi.org/10.1002/cmdc.201200243

Ronald T. Raines | Wiley-VCH Verlag GmbH
Further information:
http://www.chem.wisc.edu/users/raines
http://www.wiley-vch.de

More articles from Life Sciences:

nachricht Antibiotic resistances spread faster than so far thought
18.02.2019 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht The Lypla1 Gene Impacts Obesity in a Sex-Specific Manner
18.02.2019 | Deutsches Zentrum für Diabetesforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Light from a roll – hybrid OLED creates innovative and functional luminous surfaces

Up to now, OLEDs have been used exclusively as a novel lighting technology for use in luminaires and lamps. However, flexible organic technology can offer much more: as an active lighting surface, it can be combined with a wide variety of materials, not just to modify but to revolutionize the functionality and design of countless existing products. To exemplify this, the Fraunhofer FEP together with the company EMDE development of light GmbH will be presenting hybrid flexible OLEDs integrated into textile designs within the EU-funded project PI-SCALE for the first time at LOPEC (March 19-21, 2019 in Munich, Germany) as examples of some of the many possible applications.

The Fraunhofer FEP, a provider of research and development services in the field of organic electronics, has long been involved in the development of...

Im Focus: Regensburg physicists watch electron transfer in a single molecule

For the first time, an international team of scientists based in Regensburg, Germany, has recorded the orbitals of single molecules in different charge states in a novel type of microscopy. The research findings are published under the title “Mapping orbital changes upon electron transfer with tunneling microscopy on insulators” in the prestigious journal “Nature”.

The building blocks of matter surrounding us are atoms and molecules. The properties of that matter, however, are often not set by these building blocks...

Im Focus: University of Konstanz gains new insights into the recent development of the human immune system

Scientists at the University of Konstanz identify fierce competition between the human immune system and bacterial pathogens

Cell biologists from the University of Konstanz shed light on a recent evolutionary process in the human immune system and publish their findings in the...

Im Focus: Transformation through Light

Laser physicists have taken snapshots of carbon molecules C₆₀ showing how they transform in intense infrared light

When carbon molecules C₆₀ are exposed to an intense infrared light, they change their ball-like structure to a more elongated version. This has now been...

Im Focus: Famous “sandpile model” shown to move like a traveling sand dune

Researchers at IST Austria find new property of important physical model. Results published in PNAS

The so-called Abelian sandpile model has been studied by scientists for more than 30 years to better understand a physical phenomenon called self-organized...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Global Legal Hackathon at HAW Hamburg

11.02.2019 | Event News

The world of quantum chemistry meets in Heidelberg

30.01.2019 | Event News

Our digital society in 2040

16.01.2019 | Event News

 
Latest News

Terahertz wireless makes big strides in paving the way to technological singularity

19.02.2019 | Information Technology

Researchers find trigger that turns strep infections into flesh-eating disease

19.02.2019 | Health and Medicine

Light from a roll – hybrid OLED creates innovative and functional luminous surfaces

19.02.2019 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>